Chronic kidney disease, stage 3b
ICD-10 N18.32 is a billable code used to indicate a diagnosis of chronic kidney disease, stage 3b.
Chronic kidney disease (CKD) stage 3b is characterized by a moderate decrease in kidney function, with an estimated glomerular filtration rate (eGFR) ranging from 30 to 44 mL/min/1.73 m². This stage indicates a significant decline in renal function, which can lead to complications such as hypertension, anemia, and bone mineral disorders. Patients may experience symptoms such as fatigue, fluid retention, and changes in urination patterns. Management typically involves controlling underlying conditions like diabetes and hypertension, dietary modifications, and regular monitoring of kidney function. Patients in this stage are at increased risk for progression to end-stage renal disease (ESRD), necessitating discussions about potential renal replacement therapies, including dialysis and transplantation. Early intervention and lifestyle changes can help slow the progression of CKD and improve quality of life.
Detailed records of kidney function tests, treatment plans, and patient education.
Management of CKD progression, initiation of dialysis, and preparation for kidney transplant.
Ensure comprehensive documentation of all renal function tests and patient compliance with treatment.
Regular monitoring of kidney function, management of co-morbidities, and patient lifestyle modifications.
Routine screening for CKD in at-risk populations and management of hypertension and diabetes.
Document patient education on CKD and its implications for overall health.
Used when a patient with CKD stage 3b progresses to require dialysis.
Document the need for dialysis initiation and patient consent.
Nephrology specialists should ensure comprehensive documentation of the patient's renal status.
CKD stage 3b indicates a moderate decrease in kidney function, which requires careful management to prevent progression to end-stage renal disease and associated complications.
